Untersuchung Zur Erfassung Und Kontrolle Der Lebensqualität Unter Einer Therapie Mit Pollinex Quattro Bei Heuschnupfen

Completed

• Conditions: Rhinitis, Allergic, Seasonal
• Interventions: Other: Quality of life under or after therapy with Pollinex quattro

• Registration Number: NCT03014661
• Lead Sponsor: Universität des Saarlandes

Brief Summary

Questionnaire to measure and control the quality of life of patients with hay fever who are treated or were treated with Pollinex quattro

Detailed Description

Questionnaire including 19 questions concerning the Quality of life of patients with hayfeyer under or after therapy with a specific immuntherapy with Pollinex quattro

Study Timeline

• Study Start: 2015-06
• Primary Completion: 2015-12
• Study Completion: 2015-12
• Status Verified: 2017-01
• Study First Submitted: 2017-01-02
• Study First Submitted QC: 2017-01-05
• Last Update Submitted: 2017-01-05
• Study First Posted: 2017-01-09
• Last Update Posted: 2017-01-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 58

Inclusion Criteria

• Pollinosis/seasonal Rhinitis based on an allergy against birch/alder/Hazel pollen OR grass/rye pollen OR mugwort
• Therapy with Polinex quattro

Exclusion Criteria

• Age <18 years.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Single group study	Quality of life under or after therapy with Pollinex quattro	Single Group study investigating retrospectively the Quality of life of patients with pollinosis under or after specific immunotherapy with Pollinex quattro

Primary Outcome Measures

Name	Time	Method
Quality of life questionnaire (DLQI)	during year one, year two, year three of therapy or within 6 months after completion of therapy

Trial Locations

Locations (1)

Saarland University Hospital. Department of Dermatology; 🇩🇪 Homburg, Saarland, Germany